Trademark Overview
On Thursday, November 6, 2025, a trademark application was filed for RYPREVGO with the United States Patent and Trademark Office. The USPTO has given the RYPREVGO trademark a serial number of 99483765. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 6, 2025. This trademark is owned by Gilead Sciences Ireland UC. The RYPREVGO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of HIV infection